Zantac Cancer Lawsuits
FDA Links Ranitidine to NDMA and Cancer
You may have already heard in the news that Zantac (ranitidine) has been linked to cancer, and that recent lawsuits against Zantac manufacturers allege the drug contains a cancer-causing chemical called N-Nitrosodimethylamine (NDMA). At Baum Hedlund Aristei & Goldman, our award-winning attorneys are representing people from across the country in personal injury and wrongful death Zantac lawsuits. We intend to hold the drug makers accountable for allegedly concealing the Zantac cancer link and putting profit before people.
IMPORTANT ZANTAC UPDATE: The U.S. Food and Drug Administration announced on April 1, 2020 that it is requesting manufacturers to withdraw all Zantac and generic Zantac OTC ranitidine drugs from the market effective immediately. The FDA determined that N-Nitrosodimethylamine (NDMA) in some ranitidine medications “increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels…” The FDA, the Environmental Protection Agency (EPA), and the World Health Organization (WHO) all classify NDMA as a cancer-causing substance.
Contact Baum Hedlund at (855) 948-5098 or contact us online to see if you may be eligible to seek compensation for Zantac cancer losses.
What Is Zantac?
Chemically known as ranitidine hydrochloride, Zantac belongs to a class of drugs called histamine H2-receptor antagonists (or H2 blockers), which decrease the amount of acid produced by the stomach. Zantac is a very popular antacid medication that has been on the market since the early 1980s, available both over the counter and by prescription. People commonly use Zantac for acid reflux, heartburn, and a host of other stomach, throat, and gastrointestinal issues. Others use Zantac for allergies to supplement their treatment regimen.
Zantac dosage varies between 75 and 150 mg tablets, though some patients take a once daily Zantac 300 mg dosage.
Since the 1980s, numerous studies have demonstrated a link between the NDMA in Zantac and cancer. Mounting evidence also allegedly shows that Sanofi and Boehringer Ingelheim, the big pharma companies that make Zantac (ranitidine hydrochloride), concealed the Zantac cancer link from millions of people who took the drug for heartburn, gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), sour stomach, Barrett’s esophagus, acid reflux, and other issues. This deception came as the companies made unprecedented profits from Zantac, the first drug to generate $1 billion in sales.
Baum Hedlund continues to operate amid the Coronavirus outbreak. As the health and safety of our clients and staff remain our greatest concern, under the governmental guidelines, we are working remotely for the foreseeable future. We are fully equipped to continue to diligently represent each of our clients and accept new clients in the pursuit of justice.
Zantac Lawsuit Updates
- June 14, 2021 - Baum Hedlund Named to Plaintiffs’ Leadership in Zantac JCCP – Plaintiffs can now pursue Zantac cancer claims in California state court as part of a newly established Judicial Council Coordinated Proceedings (JCCP). The Ranitidine Product Cases JCCP 5150 is the largest state court proceeding in the country for Zantac lawsuits. Zantac attorney R. Brent Wisner was appointed to the JCCP leadership as one of two Plaintiffs’ Liaisons.
- June 8, 2020 - 40 Zantac Cancer Lawsuits Filed in California – This was our largest group of cases filed to date in California state court related to both generic ranitidine and brand name Zantac products. We filed lawsuits on behalf of 40 people with Zantac-induced cancer, including bladder cancer, kidney cancer, prostate cancer, thyroid cancer, and other cancers.
- Oct 21, 2019 - Zantac Lawsuits Seek Punitive Damages Against Drug Makers – We filed our first Zantac cases in 2019 against multiple Zantac manufacturers, including Boehringer, Sanofi, Chattem, Pfizer and GSK alleging that they knew about the NDMA defect but failed to warn consumers about its link to cancer. The lawsuits also allege the companies defectively designed Zantac and deliberately refused to test Zantac products because they knew it put people’s health in serious danger.
To stay up to date on the latest updates in the Zantac MDL and the California Zantac JCCP, please visit the Zantac Trial Schedule page.